A vaccine that could prevent HIV infection is the “holy grail” of AIDS research. In the past few years several international collaborations have brought governments, the pharmaceutical industry and private organizations together to raise money for more research, but recent setbacks have caused many within the scientific community to reconsider their approach to vaccine development. Still, a vaccine remains our greatest hope in reducing the spread of HIV, and no one’s ready to give up.